ASCO: Additional Chemo Helps Battle Oligodendroglioma скачать в хорошем качестве

ASCO: Additional Chemo Helps Battle Oligodendroglioma

Patients with newly diagnosed anaplastic oligodendroglial tumors live dramatically longer lives if PCV chemotherapy is added to standard radiation therapy, long-term follow-up from two trials shows. The benefit was greatest among patients with tumors that contain the signature chromosome 1p and 19q deletions, which occurs in about 50%-60% of patients with this rare, slow-growing brain tumor. Patients with the co-deletions experienced a 44% reduction in the risk of death, compared with a 25% risk reduction among all 368 patients in the European Organization for Research and Treatment of Cancer (EORTC) 26951 trial. To read the complete story, visit http://bit.ly/M08T6l.